- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02056483
REBECCA - Research in Rehabilitation After Breast Cancer (REBECCA)
August 5, 2015 updated by: Christoffer Johansen, Danish Cancer Society
Optimized Rehabilitation: A Randomized Study of Systematic Monitoring and Management of Breast Cancer Patients' Symptoms
The purpose of this study is to examine if a psychosocial intervention including a nurse navigator and systematic symptom screening may reduce psychological and physical symptoms as well as health behavior after breast cancer.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this pilot study with a randomized controlled trial design, we examine the effect of an intervention optimizing and integrating rehabilitation for breast cancer on psychological and physical symptoms as well as health behavior after breast cancer.
In the intervention group, we systematically screen for psychological and physical symptoms as well as health behavior (smoking alcohol and physical activity) not in line with the recommendations.
Patients who screen positive are offered a sequence of sessions with a navigator nurse who monitor rehabilitation needs, supports the patient, educate in self-management of symptoms and refer to existing rehabilitation services as well as to up to 6 free sessions with a psychologist specialized in cancer patients.
The rehabilitation services that the nurse refers to include several hospital departments and municipality services as well as general practice and by thorough follow-up on the patients use of these, the intervention aims at developing an integrated treatment and rehabilitation trajectory.
The control group receives standard care.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Rigshospitalet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- diagnosis of primary breast cancer at Breast Oncology Clinic, Rigshospitalet, Copenhagen, Denmark
- lives in Copenhagen municipality
- score ≥7 on distress thermometer
- able to read and understand Danish
- not pregnant
- expected survival more than 6 months
- physically able to participate in rehabilitation
- no severe psychiatric disease demanding treatment
- no severe cognitive problems (e.g. dementia or confusion)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual care
|
|
Experimental: Screening-based nurse navigation
Based on systematic screening for psychological and physical symptoms as well as health behavior a nurse navigator will refer to and monitor use of appropriate rehabilitation programs
|
Screening-based nurse navigation for breast cancer rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychological distress
Time Frame: 6 and 12 months
|
Difference in change in psychological distress between patients in the intervention and control group.Psychological distress wil be measured using the Distress Thermometer
|
6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health related quality of life
Time Frame: 6 and 12 months
|
Difference in change in patient reported health related quality of life between patients in the intervention and control group.
Health related quality of life will be measured using the European Organization for Research and Treatment of Cancer quality of life questionnaire EORTC QLQ C30 and the EORTC BR23 including subscales.
|
6 and 12 months
|
Anxiety and depression
Time Frame: 6 and 12 months
|
Difference in change in patient reported anxiety and depression between patients in the intervention and control group.
Anxiety and depresison will be measured using the Hospital Anxiety and Depression scale (HADS).
|
6 and 12 months
|
Smoking
Time Frame: 6 and 12 months
|
Difference in change in patient reported cigarette smoking measured in grams per day between patients in intervention and control group.
|
6 and 12 months
|
Alcohol consumption
Time Frame: 6 and 12 months
|
Difference in change in patient reported alcohol consumption measured in grams per day between patients in intervention and control group.
|
6 and 12 months
|
Body mass index
Time Frame: 6 and 12 months
|
Difference in change in patient reported body masss index between patients in intervention and control group.
|
6 and 12 months
|
Physical activity
Time Frame: 6 and 12 months
|
Difference in change in patient reported physical activity between patients in intervention and control group.
|
6 and 12 months
|
Use of rehabilitation services
Time Frame: 6 and 12 months
|
Difference in change in patient reported use of rehabilitation services between patients in intervention and control group.
|
6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christoffer Johansen, MD, Phd, Danish Cancer Society
- Principal Investigator: Pernille E Bidstrup, MA. PhD, Danish Cancer Society
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
February 5, 2014
First Submitted That Met QC Criteria
February 5, 2014
First Posted (Estimate)
February 6, 2014
Study Record Updates
Last Update Posted (Estimate)
August 7, 2015
Last Update Submitted That Met QC Criteria
August 5, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rebecca
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
-
Lawson Health Research InstituteTerminated
Clinical Trials on Screening-based nurse navigation
-
Ondokuz Mayıs UniversityCompleted
-
Hacettepe UniversityCompletedQuality of Life | Postpartum Depression | Nursing Caries | Nurse's Role | Postpartum Disorder | Postpartum AnxietyTurkey
-
Fox Chase Cancer CenterTemple UniversityRecruitingUterine Cervical NeoplasmsUnited States
-
Wake Forest University Health SciencesCompletedGastrointestinal CancerUnited States
-
University Hospital, ToulouseUnknownHematologic NeoplasmsFrance
-
Danish Cancer SocietyRigshospitalet, Denmark; Copenhagen University Hospital at HerlevCompleted
-
Odense University HospitalDanish Cancer Society; University of Southern Denmark; Laval University; Region... and other collaboratorsCompletedQuality of Life | Colorectal Neoplasms | Self Efficacy | Case Management | Continuity of Care
-
Mount Sinai Hospital, CanadaUnknownDepression | Inflammatory Bowel Diseases | Anxiety | Crohn Disease | Ulcerative ColitisCanada
-
Kilis 7 Aralik UniversityCompleted
-
Icahn School of Medicine at Mount SinaiAgency for Healthcare Research and Quality (AHRQ)CompletedCongestive Heart Failure (CHF) | Systolic DysfunctionUnited States